Those infected with COVID-19 have a 25% increased risk of being diagnosed with a psychiatric disorder in the four months following contracting the disease. The association was higher for anxiety disorders.
Babies whose mothers contracted COVID-19 while pregnant had greater difficulties relaxing and adapting their bodies while being held than those whose mothers did not contract covid. Additionally, babies born to infected mothers had greater difficulty in controlling their head and shoulder movements. Findings suggest prenatal COVID-19 infection may impact motor function development in babies.
The COVID-19 pandemic and lockdowns affected girls' mental health more than boys', researchers report. Girls' emotional and behavioral difficulties increased by 1.6% compared to boys, and this was more pronounced in girls from lower socioeconomic backgrounds.
Researchers identify the exertion level where aerosol particle emission increases exponentially, offering an explanation as to why exercise intensity may be linked to the transmission of infections.
Researchers have identified elevated levels of a biomarker in the blood that persists for months in long COVID patients who experience neuropsychiatric symptoms.
Depression, stress, and anxiety in pregnant women that occurred as a result of the COVID-29 pandemic may have an impact on fetal brain development.
Study reveals the loss of smell and taste associated with the Delta wave of COVID-19 infection was a prevalent symptom and not prevented by the vaccines. Many who contracted COVID during the earlier phases of the disease experienced loss of taste and smell for months following infection.
Researchers report a significant increase in deaths related to alcohol use disorder during the COVID-19 pandemic. The steepest increase in mortality was seen in the 25-44 age group.
Severe COVID-19 infection results in cognitive impairment similar to that sustained by natural aging between the ages of 50 to 70, and is equivalent to losing 10 IQ points.
Vaccine hesitance waned over time, and the majority of caregivers and dependents with ASD received the COVID-19 vaccine following FDA approval. However, overall vaccine hesitancy influenced COVID-19 vaccine uptake in a minority of caregivers and dependents with ASD. Recent findings reveal that those on the autism spectrum are at greater risk of hospitalization following COVID-19 infection, and historically, a significant portion of parents of children with ASD are more likely to delay or decline any childhood vaccines.